Skip to Main Content

Exclusive

Latest

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests

Exclusive Ed Silverman

STAT Plus: Doctors Without Borders is closing its widely regarded access-to-medicines campaign

Exclusive Casey Ross

STAT Plus: Republican lawmakers criticize FDA’s partnership with CHAI on regulating AI in medicine

Exclusive Rachel Cohrs Zhang

Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea

Exclusive Brittany Trang

STAT Plus: New AI for biopsies can analyze microscopy images, talk to pathologists about your tumor

Exclusive John Wilkerson

NIH wanted to make cancer research more diverse. The effort turned out to be a costly failure

Exclusive Olivia Goldhill

STAT Plus: The inside story of how Lykos’ MDMA research went awry

Exclusive Betsy Ladyzhets

NIH documents show how $1.6 billion long Covid initiative has failed so far to meet its goals

All Coverage

Exclusive Jonathan Wosen

STAT Plus: Element Biosciences, an Illumina rival, on its genomics ambitions — and why it hasn’t gone public

Exclusive Nicholas Florko

STAT Plus: NYU professors who defended vaping didn’t disclose ties to Juul, documents show

advertisement

Exclusive Adam Feuerstein

STAT Plus: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition

Exclusive Megan Molteni

Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread

Exclusive Matthew Herper

STAT Plus: Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future

Exclusive John Wilkerson

STAT Plus: Takeda is fourth big company to leave BIO since December

Exclusive Katie Palmer

STAT Plus: Accreditation agencies take on telehealth with new virtual care standards

Exclusive Annalisa Merelli

STAT Plus: How a scientific slip-up caused a pregnant woman to get an untested treatment for preterm birth

Exclusive Allison DeAngelis

STAT Plus: Cancer vaccine startup launches with $54 million, Spark veteran as CEO

Exclusive Bob Herman and Rachel Cohrs Zhang

STAT Plus: Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025

Exclusive John Wilkerson

STAT Plus: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market

Exclusive Bob Herman

STAT Plus: UnitedHealth is on a buying spree of outpatient surgery centers

Exclusive Allison DeAngelis

STAT Plus: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships

Exclusive Lizzy Lawrence

STAT Plus: Medical device lobby says it’s tired of waiting on Medicare to cover breakthrough devices

Exclusive Brittany Trang

STAT Plus: Change Healthcare cyberattack outage could persist for weeks, UnitedHealth Group executive suggests

Exclusive Allison DeAngelis

STAT Plus: Biotech launches with $82 million for Parkinson’s cell therapy

Exclusive Ed Silverman

STAT Plus: White House to hold a listening session on reforming pharmacy benefit managers

Exclusive Angus Chen

MD Anderson tried — and failed — to resolve research credit dispute between two scientists, new documents show

Exclusive Sarah Owermohle

Key congressman blasts HHS for lack of cooperation on Covid-19

Exclusive Rachel Cohrs Zhang

STAT Plus: Senators start work on Medicare physician payment reform

Exclusive Angus Chen and Jonathan Wosen

STAT Plus: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit